Policy & Regulation
Bridge Therapeutics adds Dr Steven Passik to Scientific Advisory Board
8 November 2018 -

Bridge Therapeutics, a late development-stage specialty pharmaceutical company, has added Steven Passik PhD to its Scientific Advisory Board, it was reported yesterday.

Dr Passik PhD, Clinical Psychology, is a leader and researcher in pain management and addiction. He has written extensively on the treatment of cancer and AIDS patient's pain management. He has been a principal investigator for numerous clinical trials funded by both pharmaceutical companies and government funded organisations. He has been the recipient of numerous awards for his excellence in clinical research.

Dr Greg Sullivan, chief science officer and founder of Bridge Therapeutics said, 'Dr Passik has a wealth of knowledge on the practical application of pain management in the real world, not just in the clinical setting. I'm excited to see what he will add to Bridge's efforts in developing safer chronic pain treatments.'



Related Headlines